Envestnet Asset Management Inc. Buys 16,868 Shares of National Research Corporation (NASDAQ:NRC)

Envestnet Asset Management Inc. grew its stake in National Research Corporation (NASDAQ:NRC) by 23.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 89,985 shares of the company’s stock after purchasing an additional 16,868 shares during the quarter. Envestnet Asset Management Inc. owned about 0.39% of National Research worth $1,152,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. ExodusPoint Capital Management LP boosted its position in shares of National Research by 3.4% during the fourth quarter. ExodusPoint Capital Management LP now owns 21,035 shares of the company’s stock valued at $371,000 after purchasing an additional 694 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in National Research by 5.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 14,250 shares of the company’s stock valued at $252,000 after buying an additional 752 shares during the period. Jane Street Group LLC boosted its holdings in shares of National Research by 8.6% during the 4th quarter. Jane Street Group LLC now owns 10,605 shares of the company’s stock valued at $187,000 after buying an additional 840 shares in the last quarter. Rhumbline Advisers grew its position in shares of National Research by 4.5% in the 1st quarter. Rhumbline Advisers now owns 22,204 shares of the company’s stock worth $284,000 after buying an additional 946 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of National Research by 3.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 38,565 shares of the company’s stock worth $680,000 after buying an additional 1,148 shares during the period. 47.26% of the stock is currently owned by institutional investors.

National Research Trading Up 0.6%

Shares of NASDAQ NRC opened at $12.58 on Friday. National Research Corporation has a 1 year low of $9.76 and a 1 year high of $26.02. The company has a debt-to-equity ratio of 1.98, a current ratio of 0.54 and a quick ratio of 0.54. The firm has a 50-day moving average of $15.27 and a 200 day moving average of $14.64. The stock has a market cap of $286.57 million, a P/E ratio of 16.55 and a beta of 0.44.

National Research (NASDAQ:NRC) last announced its earnings results on Monday, July 28th. The company reported $0.28 earnings per share for the quarter. National Research had a net margin of 12.78% and a return on equity of 76.61%. The business had revenue of $34.04 million during the quarter.

National Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a dividend of $0.12 per share. The ex-dividend date is Friday, September 26th. This represents a $0.48 dividend on an annualized basis and a yield of 3.8%. National Research’s payout ratio is presently 63.16%.

Insider Transactions at National Research

In related news, major shareholder Patrick E. Beans bought 2,500 shares of the company’s stock in a transaction on Monday, May 12th. The shares were acquired at an average cost of $13.59 per share, with a total value of $33,975.00. Following the completion of the acquisition, the insider owned 35,003 shares of the company’s stock, valued at $475,690.77. The trade was a 7.69% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 8.10% of the company’s stock.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.